Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Alice S. Rim, MD, is Vice Chairman of the Imaging Institute and Section Head of Breast Imaging in the Department of Diagnostic Radiology at Cleveland Clinic. Dr. Rim joined Cleveland Clinic in 1999 after serving as staff radiologist and breast/body imager at the Watson Clinic, Lakeland, Fla., and previously as staff radiologist at McCullough/Hyde Hospital in Oxford, Ohio. She is board-certified in diagnostic radiology by the American Board of Radiology and holds licenses from the states of Ohio, Florida, Tennessee, New York, Illinois and Michigan. Her specialty interests include interventional breast imaging, breast MRI and high-risk screening.
Dr. Rim received her bachelor’s of science degree from Northwestern University and her medical degree from the Medical College of Ohio at Toledo. Her postgraduate training includes an internal medicine internship at the University of Pittsburgh and a radiology residency and breast/body imaging fellowship at the University of Cincinnati.
A frequent presenter and lecturer at medical conferences across the country, Dr. Rim also has co-authored numerous articles on diagnostic imaging and related topics that have appeared in publications such as the American Journal of Surgery and The Breast Journal. Current works in progress include MRI vs. Mammography for Screening Pre-menopausal Women At High-Risk for Breast Cancer: A Prospective Randomized Trial and Computed Tomography Laser Mammography (CTLM) Breast-Imaging Device Model 1020.
Dr. Rim is a member of the American College of Radiology, the American Roentgen Ray Society, the Radiological Society of North America and the Society of Breast Imaging.
breast MRI, high risk screening, interventional breast imaging
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 8/20/2015, Dr. Rim has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.